Various carbapenemases such as NDM-types, KPCtypes, and OXA-types have recently emerged and spread worldwide (1) . Among these carbapenemases, OXA-types have been identified mainly in Acinetobacter spp., particularly in Acinetobacter baumannii (2). OXA-type carbapenemases in A. baumannii were shown to be OXA-51-like, OXA-23-like, OXA-24/40-like, and OXA-58-like. However, OXA-48 was first identified from Klebsiella pneumoniae clinically isolated in Turkey in 2001 (3). After 2009, OXA-48-producing K. pneumoniae spread rapidly among European countries and caused several outbreaks in hospital settings (4-6). The first cases in the United States were recently identified (7), although OXA-48-producing Gram-negative bacteria belonging to the family Enterobacteriaceae have been reported in several developing countries or regions (8, 9) .
In November 2012, a man in his 60s was admitted to a general hospital in Kanto. This patient had a history of hospitalization in a Southeast Asian country for the treatment of cerebral infarction before admission to the hospital. Three types of antimicrobial-resistant microbes belonging to the family Enterobacteriaceae, namely, multidrug-resistant K. pneumoniae and Escherichia coli, as well as piperacillin-tazobactam-resistant K. pneumoniae, were isolated from the sputa and/or feces of this patient. The minimum inhibitory concentrations (MICs) of imipenem (IPM) and meropenem *Typical expansion of growth area of E. coli ATCC25922 toward the ertapenem disk along the streak of OXA-48-producing E. coli was observed, suggesting production of carbapenemase. **This phenomenon suggested probable production of class A enzymes such as ESBL. ***In each antimicrobial, atypical slight expansion of growth inhibition zone was observed toward the center disk containing clavulanate/amoxicillin. Growth of E. coli ATCC25922, a carbapenem-susceptible reference strain, expands to the ertapenem disk along the streak of the E. coli strain Ec, shown in Table 1 , suggesting the production of carbapenemase in the Ec. (B) and (C) Double disk synergy tests for E. coli strain Ec and K. pneumoniae strain Kp2. Since these strains produce both OXA-48 and CTX-M-type ESBL, the patterns of the growth inhibition zone around the disks containing ceftazidime (CAZ), cefotaxime, or aztreonam with clavulanic acid became atypical. In clinical isolates demonstrating atypical growth inhibition profiles with clavulanic acid and CAZ or cefotaxime increased, production of multiple and different types of b-lactamases should be considered.
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(MEPM) for these isolates were below the breakpoint for``resistant,'' but two multidrug-resistant isolates, Kp2 and Ec (Table 1) , consistently showed resistance to various broad-spectrum b-lactams, including cefotaxime, ceftazidime (CAZ), cefpirome, and cefepime, together with aminoglycosides and fluoroquinolones. In contrast, a piperacillin-tazobactamresistant K. pneumonia isolate, Kp1 (Table 1) , was found to be susceptible to many b-lactams. Inhibition tests for discriminating between b-lactamases produced in the isolates using sodium mercaptoacetate (SMA), EDTA, and 3-aminophenylboronic acid (APB) were all negative, but a modified Hodge test using the ertapenem disk indicated production of carbapenemases in these isolates (Fig. 1A) . Polymerase chain reaction (PCR) analyses of carbapemase genes (10,11) such as bla NDM , bla IMP , bla VIM , bla KPC , and bla OXA including bla OXA-51-like , bla OXA-23-like , bla OXA-24/40-like , bla OXA-58-like , and bla OXA-48-like showed the presence of the bla OXA-48-like gene in these isolates. PCR analysis showed that two multidrug-resistant isolates, Kp2 and Ec, as shown in Table 1 , were also found to harbor a gene for the CTX-M-1-group ESBL. The MICs of CAZ for these isolates declined from À128 mg/ml to 4 or 16 mg/ml in the presence of 4 mg/ml clavulanate, suggesting the role of the ESBL production in CAZ resistance. Since these isolates co-produced the CTX-M-1-group ESBL and OXA-48, a double disk synergy test using a clavulanate/ ampicillin disk with disks containing CAZ, cefotaxime, or aztreonam showed atypical inhibition profiles (Figs.  1B and 1C) . Interestingly, the E. coli isolate was not agglutinated with anti-sera specific for E. coli serotype O25, although ESBL-producing and fluoroquinolone resistant E. coli clinical isolates are usually O25:H4-ST131, a global epidemic lineage. Moreover, an A. baumannii that harbors genes for acquired OXA-23-like carbapenemase and ArmA 16S rRNA methyltransferase was co-isolated from this patient.
It has been reported that some clinical isolates werè`s usceptible'' to carbapenems despite harboring carbapenemase genes such as bla NDM , bla KPC , and bla OXA . Therefore, clinical isolates suspected to be ESBL producers due to demonstrating consistent resistance to various cephalosporins and reduced susceptibility (MIC, 2-4 mg/ml) to carbapenems would worth being subjected to PCR analyses using PCR primer sets for detecting known carbapenemase genes after screening using modified Hodge test (12) . Furthermore, even in cases in which the clinical isolates show susceptibility to broad-spectrum b-lactams as found in the piperacillintazobactam-resistant K. pneumoniae (Kp1 in Table 1 ), the resistance profile to piperacillin-tazobactam may be a good marker for detecting KPC-or OXA-typecarbapenemase producers in addition to the modified Hodge test. Two types of new carbapenemases, the NDM-1 and KPC-2, have already been identified in Gram-negative microbes in Japan, and OXA-48-like carbapenemase was newly identified in K. pneumoniae and E. coli in this study. Hence, early detection of invasion of carbapenemase-producing Gram-negative microbes and their containment in clinical settings is currently very important in Japan, where NDM, KPC, and OXA producers remain very rare. Furthermore, intensive surveillance of OXA-type carbapenemaseproducing Gram-negative microbes should be conducted in Asian countries, as well as enhanced surveillance of NDM and/or KPC producers because OXA-181, a variant of OXA-48, has already spread in India (13) . Positive results in the modified Hodge test using an ertapenem disk (14) , as well as multidrug-resistance profiles, including piperacillin-tazobactam, are useful in the early detection of OXA-48-like carbapenemaseproducing Gram-negative microbes.
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